HomeNAMS • NASDAQ
add
NewAmsterdam Pharma Company NV
Previous close
$26.60
Day range
$24.19 - $26.67
Year range
$14.06 - $27.35
Market cap
2.72B USD
Avg Volume
940.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 19.14M | 740.06% |
Operating expense | 54.78M | -0.13% |
Net income | -17.36M | 55.48% |
Net profit margin | -90.70 | 94.70% |
Earnings per share | -0.13 | 65.63% |
EBITDA | -35.59M | 32.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 739.16M | 71.62% |
Total assets | 815.11M | 82.48% |
Total liabilities | 36.62M | -38.20% |
Total equity | 778.50M | — |
Shares outstanding | 112.63M | — |
Price to book | 3.84 | — |
Return on assets | -10.91% | — |
Return on capital | -11.45% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -17.36M | 55.48% |
Cash from operations | -37.67M | 30.21% |
Cash from investing | -159.14M | -76,041.63% |
Cash from financing | 3.42M | -26.47% |
Net change in cash | -184.56M | -265.90% |
Free cash flow | -33.37M | 29.51% |
About
Founded
2019
Website
Employees
77
